Challenges in the development of magnetic particles for therapeutic applications

References

• Oliver JD, 3rd, Deen WM. Random-coil model for glomerular sieving of dextran. Bull Math Biol 1994; 56: 369–389
   PubMed Web of Science ®Google Scholar
• Huang SK, Lee KD, Hong K, Friend DS, Papahadjopoulos D. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res 1992; 52: 5135–5143
   PubMed Web of Science ®Google Scholar
• Tang T, Howarth SP, Miller SR, Trivedi R, Graves MJ, King-Im JU, Li ZY, Brown AP, Kirkpatrick PJ, Gaunt ME, Gillard JH. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 2006; 37: 2266–2270
   PubMed Web of Science ®Google Scholar
• Yancy AD, Olzinski AR, Hu TC, Lenhard SC, Aravindhan K, Gruver SM, Jacobs PM, Willette RN, Jucker BM. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: Critical determinants of atherosclerotic plaque labeling. J Magn Reson Imaging 2005; 21: 432–442
   PubMed Web of Science ®Google Scholar
• Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000; 156: 1363–1380
   PubMed Web of Science ®Google Scholar
• Rudge SR, Kurtz TL, Vessely CR, Catterall LG, Williamson DL. Preparation, characterization, and performance of magnetic iron-carbon composite microparticles for chemotherapy. Biomaterials 2000; 21: 1411–1420
   PubMed Web of Science ®Google Scholar
• Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 2001; 41: 189–207
   PubMedGoogle Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 2000; 65: 271–284
   PubMed Web of Science ®Google Scholar
• Jang SH, Wientjes MG, Lu D, Au JL. Drug delivery and transport to solid tumors. Pharm Res 2003; 20: 1337–1350
   PubMed Web of Science ®Google Scholar
• Dreher MR, Liu W, Michelich CR, Dewhirst MW, Yuan F, Chilkoti A. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst 2006; 98: 335–344
   PubMed Web of Science ®Google Scholar
• Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size. Cancer Res 1995; 55: 3752–3756
   PubMed Web of Science ®Google Scholar
• Yuan F, Krol A, Tong S. Available space and extracellular transport of macromolecules: Effects of pore size and connectedness. Ann Biomed Eng 2001; 29: 1150–1158
   PubMed Web of Science ®Google Scholar
• Lee CC, Gillies ER, Fox ME, Guillaudeu SJ, Frechet JM, Dy EE, Szoka FC. A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc Natl Acad Sci USA 2006; 103: 16649–16654
   PubMed Web of Science ®Google Scholar
• Satchi-Fainaro R, Hailu H, Davies JW, Summerford C, Duncan R. PDEPT: Polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination. Bioconjug Chem 2003; 14: 797–804
   PubMed Web of Science ®Google Scholar
• Charrois GJ, Allen TM. Rate of biodistribution of STEALTH liposomes to tumor and skin: Influence of liposome diameter and implications for toxicity and therapeutic activity. Biochim Biophys Acta 2003; 1609: 102–108
   PubMed Web of Science ®Google Scholar
• Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 1999; 51: 691–743
   PubMed Web of Science ®Google Scholar
• Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D: Applied Phys 2003; 36: 81
   Web of Science ®Google Scholar
• McRobbie DW. MRI from picture to proton. Cambridge University Press, Cambridge 2003
   Google Scholar
• Corot C, Robert P, Idee JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006; 58: 1471–1504
   PubMed Web of Science ®Google Scholar
• Oude Engberink RD, van der Pol SM, Dopp EA, de Vries HE, Blezer EL. Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Radiology 2007; 243: 467–474
   PubMed Web of Science ®Google Scholar
• Daldrup H, Shames DM, Wendland M, Okuhata Y, Link TM, Rosenau W, Lu Y, Brasch RC. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media. Pediatr Radiol 1998; 28: 67–78
   PubMed Web of Science ®Google Scholar
• Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1–8
   PubMed Web of Science ®Google Scholar
• Daldrup-Link HE, Rydland J, Helbich TH, Bjornerud A, Turetschek K, Kvistad KA, Kaindl E, Link TM, Staudacher K, Shames D, Brasch RC, Haraldseth O, Rummeny EJ. Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial. Radiology 2003; 229: 885–892
   PubMed Web of Science ®Google Scholar
• Turetschek K, Huber S, Floyd E, Helbich T, Roberts TP, Shames DM, Tarlo KS, Wendland MF, Brasch RC. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. Radiology 2001; 218: 562–569
   PubMed Web of Science ®Google Scholar
• Shames DM, Kuwatsuru R, Vexler V, Muhler A, Brasch RC. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: A quantitative noninvasive technique. Magn Reson Med 1993; 29: 616–622
   PubMed Web of Science ®Google Scholar
• Brasch RC, Shames DM, Cohen FM, Kuwatsuru R, Neuder M, Mann JS, Vexler V, Muhler A, Rosanau W. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas. Invest Radiol 1994; 29: S8–S11
   PubMed Web of Science ®Google Scholar
• Funovics MA, Kapeller B, Hoeller C, Su HS, Kunstfeld R, Puig S, Macfelda K. MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents. Magn Reson Imaging 2004; 22: 843–850
   PubMed Web of Science ®Google Scholar
• Choi H, Choi SR, Zhou R, Kung HF, Chen IW. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol 2004; 11: 996–1004
   PubMed Web of Science ®Google Scholar
• Montet X, Montet-Abou K, Reynolds F, Weissleder R, Josephson L. Nanoparticle imaging of integrins on tumor cells. Neoplasia 2006; 8: 214–222
   PubMed Web of Science ®Google Scholar
• Widder KJ, Senyei AE. Magnetic microspheres: A vehicle for selective targeting of drugs. Pharmacol Ther 1983; 20: 377–395
   PubMed Web of Science ®Google Scholar
• Cheng J, Teply BA, Jeong SY, Yim CH, Ho D, Sherifi I, Jon S, Farokhzad OC, Khademhosseini A, Langer RS. Magnetically responsive polymeric microparticles for oral delivery of protein drugs. Pharm Res 2006; 23: 557–564
   PubMed Web of Science ®Google Scholar
• Inada Y, Ohwada K, Yoshimoto T, Kojima S, Takahashi K, Kodera Y, Matsushima A, Saito Y. Fibrinolysis by urokinase endowed with magnetic property. Biochem Biophys Res Commun 1987; 148: 392–396
   PubMed Web of Science ®Google Scholar
• Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm 2005; 2: 194–205
   PubMed Web of Science ®Google Scholar
• Kohler N, Fryxell GE, Zhang M. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J Am Chem Soc 2004; 126: 7206–7211
   PubMed Web of Science ®Google Scholar
• Laconte LE, Nitin N, Zurkiya O, Caruntu D, O'Connor CJ, Hu X, et al. Coating thickness of magnetic iron oxide nanoparticles affects R(2) relaxivity. J Magn Reson Imaging 2007; 26(6)1634–1641
   PubMed Web of Science ®Google Scholar
• Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, Muller RH. ‘Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): Influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 2000; 18: 301–313
   PubMed Web of Science ®Google Scholar
• Immordino ML, Dosio F, Cattel L. Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 2006; 1: 297–315
   PubMed Web of Science ®Google Scholar
• Gupta AK, Naregalkar RR, Vaidya VD, Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomed 2007; 2: 23–39
   PubMed Web of Science ®Google Scholar
• Spinowitz BS, Schwenk MH, Jacobs PM, Bolton WK, Kaplan MR, Charytan C, Galler M. The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients. Kidney Int 2005; 68: 1801–1807
   PubMed Web of Science ®Google Scholar
• Theil EC. Ferritin: At the crossroads of iron and oxygen metabolism. J Nutr 2003; 133: S1549–S1553
   PubMed Web of Science ®Google Scholar
• Cowley JM, Janney DE, Gerkin RC, Buseck PR. The structure of ferritin cores determined by electron nanodiffraction. J Struct Biol 2000; 131: 210–216
   PubMed Web of Science ®Google Scholar
• Glickstein H, El RB, Link G, Breuer W, Konijn AM, Hershko C, Nick H, Cabantchik ZI. Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequences. Blood 2006; 108: 3195–3203
   PubMed Web of Science ®Google Scholar
• Yee J, Besarab A. Iron sucrose: The oldest iron therapy becomes new. Am J Kidney Dis 2002; 40: 1111–1121
   PubMed Web of Science ®Google Scholar
• Kudasheva DS, Lai J, Ulman A, Cowman MK. Structure of carbohydrate-bound polynuclear iron oxyhydroxide nanoparticles in parenteral formulations. J Inorg Biochem 2004; 98: 1757–1769
   PubMed Web of Science ®Google Scholar
• Kumar CS, Leuschner C, Urbina M, Ozkaya T, Hormes J. Glutaric acid as a spacer facilitates improved intracellular uptake of LHRH-SPION into human breast cancer cells. Int J Nanomedicine 2007; 2: 175–179
   PubMed Web of Science ®Google Scholar
• Zhou J, Leuschner C, Kumar C, Hormes JF, Soboyejo WO. Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases. Biomaterials 2006; 27: 2001–2008
   PubMed Web of Science ®Google Scholar
• Gorantla S, Dou H, Boska M, Destache CJ, Nelson J, Poluektova L, Rabinow BE, Gendelman HE, Mosley RL. Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery. J Leukoc Biol 2006; 80: 1165–1174
   PubMed Web of Science ®Google Scholar
• Dou H, Destache CJ, Morehead JR, Mosley RL, Boska MD, Kingsley J, Gorantla S, Poluektova L, Nelson JA, Chaubal M, Werling J, Kipp J, Rabinow BE, Gendelman HE. Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Blood 2006; 108: 2827–2835
   PubMed Web of Science ®Google Scholar
• Sonvico F, Mornet S, Vasseur S, Dubernet C, Jaillard D, Degrouard J, Hoebeke J, Duguet E, Colombo P, Couvreur P. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: Synthesis, physicochemical characterization, and in vitro experiments. Bioconjug Chem 2005; 16: 1181–1188
   PubMed Web of Science ®Google Scholar
• Ito A, Kuga Y, Honda H, Kikkawa H, Horiuchi A, Watanabe Y, Kobayashi T. Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia. Cancer Lett 2004; 212: 167–175
   PubMed Web of Science ®Google Scholar
• Allen TM, Sapra P, Moase E, Moreira J, Iden D. Adventures in targeting. J Liposome Res 2002; 12: 5–12
   PubMed Web of Science ®Google Scholar
• Sapra P, Allen TM. Ligand-targeted liposomal anticancer drugs. Prog Lipid Res 2003; 42: 439–462
   PubMed Web of Science ®Google Scholar
• Fahmy TM, Fong PM, Goyal A, Saltzman WM. Targeted for drug delivery. Materials Today 2005; 8: 18–26
   Web of Science ®Google Scholar
• Goodman TT, Olive PL, Pun SH. Increased nanoparticle penetration in collagenase-treated multicellular spheroids. Int J Nanomedicine 2007; 2: 265–274
   PubMed Web of Science ®Google Scholar
• Kuhn SJ, Finch SK, Hallahan DE, Giorgio TD. Proteolytic surface functionalization enhances in vitro magnetic nanoparticle mobility through extracellular matrix. Nano Lett 2006; 6: 306–312
   PubMed Web of Science ®Google Scholar
• Yoshimoto T, Ohwada K, Takahashi K, Matsushima A, Saito Y, Inada Y. Magnetic urokinase: Targeting of urokinase to fibrin clot. Biochem Biophys Res Commun 1988; 152: 739–743
   PubMed Web of Science ®Google Scholar
• Pichl L, Heitmann A, Herzog P, Oster J, Smets H, Schottstedt V. Magnetic bead technology in viral RNA and DNA extraction from plasma minipools. Transfusion 2005; 45: 1106–1110
   PubMed Web of Science ®Google Scholar
• Veyret R, Elaissari A, Marianneau P, Sall AA, Delair T. Magnetic colloids for the generic capture of viruses. Anal Biochem 2005; 346: 59–68
   PubMed Web of Science ®Google Scholar
• Williams SF, Lee WJ, Bender JG, Zimmerman T, Swinney P, Blake M, Carreon J, Schilling M, Smiths S, Williams DE, Oldham F, Van Epps D. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood 1996; 87: 1687–1691
   PubMed Web of Science ®Google Scholar
• Denis MG, Lipart C, Leborgne J, LeHur PA, Galmiche JP, Denis M, Ruud E, Truchaud A, Lustenberger P. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer 1997; 74: 540–544
   PubMed Web of Science ®Google Scholar
• Zigeuner RE, Riesenberg R, Pohla H, Hofstetter A, Oberneder R. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro. J Urol 2003; 169: 701–705
   PubMed Web of Science ®Google Scholar
• Chen H, Kaminski MD, Liu X, Mertz CJ, Xie Y, Torno MD, Rosengart AJ. A novel human detoxification system based on nanoscale bioengineering and magnetic separation techniques. Med Hypotheses 2007; 68: 1071–1079
   PubMed Web of Science ®Google Scholar
• Driscoll CF, Morris RM, Senyei AE, Widder KJ, Heller GS. Magnetic targeting of microspheres in blood flow. Microvasc Res 1984; 27: 353–369
   PubMed Web of Science ®Google Scholar
• Gupta PK, Hung CT. Magnetically controlled targeted micro-carrier systems. Life Sci 1989; 44: 175–186
   PubMed Web of Science ®Google Scholar
• Lubbe AS, Alexiou C, Bergemann C. Clinical applications of magnetic drug targeting. J Surg Res 2001; 95: 200–206
   PubMed Web of Science ®Google Scholar
• Goodwin S, Peterson C, Hoh C, Bittner C. Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy. J Magn Magn Mat 1999; 194: 132–139
   Web of Science ®Google Scholar
• Rudge S, Peterson C, Vessely C, Koda J, Stevens S, Catterall L. Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC). J Control Release 2001; 74: 335–340
   PubMed Web of Science ®Google Scholar
• Goodwin SC, Bittner CA, Peterson CL, Wong G. Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier. Toxicol Sci 2001; 60: 177–183
   PubMed Web of Science ®Google Scholar
• Widder K, Flouret G, Senyei A. Magnetic microspheres: Synthesis of a novel parenteral drug carrier. J Pharm Sci 1979; 68: 79–82
   PubMed Web of Science ®Google Scholar
• Senyei AE, Driscoll CF, Widder KJ. Biophysical drug targeting: Magnetically responsive albumin microspheres. Methods Enzymol 1985; 112: 56–67
   PubMed Web of Science ®Google Scholar
• Lubbe AS, Bergemann C, Riess H, Schriever F, Reichardt P, Possinger K, Matthias M, Dorken B, Herrmann F, Gurtler R, Hohenberger P, Haas N, Sohr R, Sander B, Lemke AJ, Ohlendorf D, Huhnt W, Huhn D. Clinical experiences with magnetic drug targeting: A phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res 1996; 56: 4686–4693
   PubMed Web of Science ®Google Scholar
• Lesieur S, Grabielle-Madelmont C, Menager C, Cabuil V, Dadhi D, Pierrot P, Edwards K. Evidence of surfactant-induced formation of transient pores in lipid bilayers by using magnetic-fluid-loaded liposomes. J Am Chem Soc 2003; 125: 5266–5267
   PubMed Web of Science ®Google Scholar
• Fortin-Ripoche JP, Martina MS, Gazeau F, Menager C, Wilhelm C, Bacri JC, Lesieur S, Clement O. Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: Feasibility. Radiology 2006; 239: 415–424
   PubMed Web of Science ®Google Scholar
• Gilchrest R, Medal R, Shorey W, Hanselman R, Parrott J, Taylor C. Selective inductive heating of lymph nodes. Ann Surg 1957; 146: 596–606
   PubMed Web of Science ®Google Scholar
• Jordan A, Scholz R, Wust P, Fahling H, Felix R. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mat 1999; 201: 413–419
   Web of Science ®Google Scholar
• Johannsen M, Gneveckow U, Eckelt L, Feussner A, Waldofner N, Scholz R, Deger S, Wust P, Loening SA, Jordan A. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique. Int J Hyperthermia 2005; 21: 637–647
   PubMed Web of Science ®Google Scholar
• Merkle EM, Boll DT, Boaz T, Duerk JL, Chung YC, Jacobs GH, Varnes ME, Lewin JS. MRI-guided radiofrequency thermal ablation of implanted VX2 liver tumors in a rabbit model: Demonstration of feasibility at 0.2 T. Magn Reson Med 1999; 42: 141–149
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Vujaskovic Z, Jones E, Thrall D. Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia 2005; 21: 779–790
   PubMed Web of Science ®Google Scholar
• Bicher HI, Hetzel FW, Sandhu TS, Frinak S, Vaupel P, O'Hara MD, O′Brien T. Effects of hyperthermia on normal and tumor microenvironment. Radiology 1980; 137: 523–530
   PubMed Web of Science ®Google Scholar
• Vaupel P, Muller-Klieser W, Otte J, Manz R. Impact of various thermal doses on the oxygenation and blood flow in malignant tumors upon localized hyperthermia. Adv Exp Med Biol 1984; 169: 621–629
   PubMed Web of Science ®Google Scholar
• Vaupel PW. The influence of tumor blood flow and microenvironmental factors on the efficacy of radiation, drugs and localized hyperthermia. Klin Padiatr 1997; 209: 243–249
   PubMed Web of Science ®Google Scholar
• Song CW, Park H, Griffin RJ. Improvement of tumor oxygenation by mild hyperthermia. Radiat Res 2001; 155: 515–528
   PubMed Web of Science ®Google Scholar
• Cope DA, Dewhirst MW, Friedman HS, Bigner DD, Zalutsky MR. Enhanced delivery of a monoclonal antibody F(ab')2 fragment to subcutaneous human glioma xenografts using local hyperthermia. Cancer Res 1990; 50: 1803–1809
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res 2000; 60: 4440–4445
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res 2001; 61: 3027–3032
   PubMed Web of Science ®Google Scholar
• Hergt R, Dutz S, ller R, Zeisberger M. Magnetic particle hyperthermia: Nanoparticle magnetism and materials development for cancer therapy. J Phys Condensed Matter 2006; 18: S2919–S34
   Web of Science ®Google Scholar
• Brezovich I. Low frequency hyperthermia. Med Phys Mono 1988; 16: 82–111
   Google Scholar
• Hilger I, Hergt R, Kaiser WA. Use of magnetic nanoparticle heating in the treatment of breast cancer. IEE Proc-Nanobiotechnol 2005; 152: 33–38
   PubMedGoogle Scholar
• Molday RS. inventor, Canadian Patents and Development, Ltd, assignee, Magnetic iron dextran microspheres 1984, USA patent 4452773
   Google Scholar
• Palmacci S, Josephson L. inventors, Advanced Magnetics, Inc., assignee, Synthesis of polysaccharide covered superparamagnetic oxide colloids 1993, USA patent 5262176
   Google Scholar
• Hyeon T, Lee S, Park J, Chung Y, Bin Na H. Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J Am Chemical Society 2001; 123: 12798–12801
   PubMed Web of Science ®Google Scholar
• Sun S, Zeng H, Robinson DB, Raoux S, Rice PM, Wang SX, Li G. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc 2004; 126: 273–279
   PubMed Web of Science ®Google Scholar
• Rabin Y. Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense?. Int J Hyperthermia 2002; 18: 194–202
   PubMed Web of Science ®Google Scholar
• Andra W, d'Ambly CG, Hergt R, Hilger I, Kaiser WA. Temperature distribution as function of time around a small spherical heat source of local magnetic hyperthermia. J Magn Magn Mat 1999; 194: 197–203
   Web of Science ®Google Scholar
• Hergt R, Hiergeist R, Hilger I, Kaiser WA, Lapatnikov Y, Margel S, Richter U. Maghemite nanoparticles with very high AC-losses for application in RF-magnetic hyperthermia. J Magn Magn Mat 2004; 270: 345–357
   Web of Science ®Google Scholar
• DeNardo SJ, DeNardo GL, Natarajan A, Miers LA, Foreman AR, Gruettner C, Adamson GN, Ivkov R. Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF-induced thermoablative therapy for human breast cancer in mice. J Nucl Med 2007; 48: 437–444
   PubMed Web of Science ®Google Scholar
• Ivkov R, DeNardo SJ, Daum W, Foreman AR, Goldstein RC, Nemkov VS, De Nardo GL. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer. Clin Cancer Res 2005; 11: S7093–7103
   PubMed Web of Science ®Google Scholar
• Bergey E, Levy L, Wang X, Krebs L, Lal M, Kim K, Pakatchi S, Liebow C, Prasad P. DC magnetic field induced magnetocytolysis of cancer cells targeted by LH-RH magnetic nanoparticles in vitro. Biomedical Microdevices 2002; 4: 293–299
   Web of Science ®Google Scholar
• Halbreich A, Roger J, Pons JN, Geldwerth D, Da Silva MF, Roudier M, Bacri JC. Biomedical applications of maghemite ferrofluid. Biochimie 1998; 80: 379–390
   PubMed Web of Science ®Google Scholar
• Lee JH, Huh YM, Jun YW, Seo JW, Jang JT, Song HT, Kim S, Cho EJ, Yoon HG, Suh JS, Cheon J. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007; 13: 95–99
   PubMed Web of Science ®Google Scholar
• Qiang Y, Antony J, Sharma A, Nutting J, Sikes D, Meyer D. Iron/iron oxide core-shell nanoclusters for biomedical applications. J Nanoparticle Res 2006; 8: 489–496
   Web of Science ®Google Scholar
• Meyer DE, Shin BC, Kong GA, Dewhirst MW, Chilkoti A. Drug targeting using thermally responsive polymers and local hyperthermia. J Control Release 2001; 74: 213–224
   PubMed Web of Science ®Google Scholar
• Bae Y, Buresh RA, Williamson TP, Chen TH, Furgeson DY. Intelligent biosynthetic nanobiomaterials for hyperthermic combination chemotherapy and thermal drug targeting of HSP90 inhibitor geldanamycin. J Control Release 2007; 122: 16–23
   PubMed Web of Science ®Google Scholar
• Needham D, Anyarambhatla G, Kong G, Dewhirst MW. A new temperature-sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model. Cancer Res 2000; 60: 1197–1201
   PubMed Web of Science ®Google Scholar
• Alvarez Secord A, Jones EL, Hahn CA, Petros WP, Yu D, Havrilesky LJ, Soper JT, Berchuck A, Spasojevic I, Clarke-Pearson DL, Prosnitz LR, Dewhirst MW. Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer. Int J Hyperthermia 2005; 21: 333–347
   PubMed Web of Science ®Google Scholar
• Babincova M, Altanerova V, Altaner C, Cicmanec P, Babinec P. In vivo heating of magnetic nanoparticles in alternating magnetic field. Med Phys 2004; 31: 2219–2221
   PubMed Web of Science ®Google Scholar
• Babincova M, Cicmanec P, Altanerova V, Altaner C, Babinec P. AC-magnetic field controlled drug release from magnetoliposomes: Design of a method for site-specific chemotherapy. Bioelectrochemistry 2002; 55: 17–19
   PubMed Web of Science ®Google Scholar
• Li GP, Zhang H, Zhu CM, Zhang J, Jiang XF. Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma. World J Gastroenterol 2005; 11: 6288–6294
   PubMed Web of Science ®Google Scholar
• Colbern GT, Hiller AJ, Musterer RS, Working PK, Henderson IC. Antitumor activity of Herceptin in combination with STEALTH liposomal cisplatin or nonliposomal cisplatin in a HER2 positive human breast cancer model. J Inorg Biochem 1999; 77: 117–120
   PubMed Web of Science ®Google Scholar
• Muggia FM, Fojo T. Platinums: Extending their therapeutic spectrum. J Chemother 2004; 16: 77–82
   PubMed Web of Science ®Google Scholar
• Livingston RB. Combined modality therapy of lung cancer. Clin Cancer Res 1997; 3: 2638–2647
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Lee SH, Rood KL, Stewart MJ, Lyons JC, Lew YS, Park H, Song CW. Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors. Neoplasia 2000; 2: 555–560
   PubMed Web of Science ®Google Scholar
• Masunaga S, Ono K, Hori H, Kinashi Y, Suzuki M, Takagaki M, Kasai S, Nagasawa H, Uto Y. Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: Reference to effect on quiescent tumour cells. Int J Hyperthermia 1999; 15: 7–16
   PubMed Web of Science ®Google Scholar
• Akaboshi M, Tanaka Y, Kawai K, Akuta K, Masunaga S, Ono K. Effect of hyperthermia on the number of platinum atoms binding to DNA of HeLa cells treated with 195mPt-radiolabelled cis-diaminedichloroplatinum(II). Int J Radiat Biol 1994; 66: 215–220
   PubMed Web of Science ®Google Scholar
• Masunaga S, Nagata K, Suzuki M, Kashino G, Kinashi Y, Ono K. Inhibition of repair of radiation-induced damage by mild temperature hyperthermia, referring to the effect on quiescent cell populations. Radiat Med 2007; 25: 417–425
   PubMedGoogle Scholar
• Xu M, Myerson RJ, Xia Y, Whitehead T, Moros EG, Straube WL, Roti JL. The effects of 41°C hyperthermia on the DNA repair protein, MRE11, correlate with radiosensitization in four human tumor cell lines. Int J Hyperthermia 2007; 23: 343–351
   PubMed Web of Science ®Google Scholar
• Raaphorst GP, Maio J, Ng CE, Stewart DJ. Concomitant treatment with mild hyperthermia, cisplatin and low dose-rate irradiation in human ovarian cancer cells sensitive and resistant to cisplatin. Oncol Rep 1998; 5: 971–977
   PubMed Web of Science ®Google Scholar
• Raaphorst GP, Miao J, Stewart D, Ng CE. Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells. Cancer Chemother Pharmacol 1998; 41: 491–496
   PubMed Web of Science ®Google Scholar
• Sunderland CJ, Steiert M, Talmadge JE, Derfus AM, Barry SE. Targeted nanoparticles for detecting and treating cancer. Drug Development Research 2006; 67: 70–93
   Web of Science ®Google Scholar
• Douwes F, Bogovi CJ, Douwes O, Migeod F, Grote C. Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer. Int J Clin Oncol 2004; 9: 85–91
   PubMedGoogle Scholar
• Kusumoto T, Holden SA, Ara G, Teicher BA. Hyperthermia and platinum complexes: Time between treatments and synergy in vitro and in vivo. Int J Hyperthermia 1995; 11: 575–586
   PubMed Web of Science ®Google Scholar
• Westermann AM, Grosen EA, Katschinski DM, Jager D, Rietbroek R, Schink JC, Tiggelaar CL, Jager E, Zum Vorde sive Vording P, Neuman A, Knuth A, Van Dijk JD, Wiedemann GJ, Robins HI. A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer. Eur J Cancer 2001; 37: 1111–1117
   PubMed Web of Science ®Google Scholar